Author/Editor		Ramagopalan, Sreeram V; Cukjati, Marko; Černilec, Maja; DeLuca, Gabriele C; Dyment, David A; Degenhardt, Alexandra; Sadovnick, A Dessa; Čurin-Šerbec, Vladka; Ebers, George C; Duquette, Pierre
Title		Mutations in the hemochromatosis gene and the clinical outcome of multiple sclerosis
Type		članek
Source		J Neuroimmunol
Vol. and No.		Letnik 203, št. 1
Publication year		2008
Volume		str. 104-7
Language		eng
Abstract		Multiple sclerosis (MS) is a common inflammatory disease of the central nervous system unsurpassed for its variability in disease outcome. Given a possible role for dysregulation of iron metabolism in MS disease pathogenesis, we investigated whether or not mutations in the HFE gene influence the prognosis of the disease. A cohort of sporadic MS cases, taken from opposite extremes of the putative distribution of long-term outcome using the most stringent clinical criteria to date, was used to determine the role of HFE on MS disease severity. This approach increases the effective sample size by some 40-fold. Genotyping the two sets of MS patients (112 benign and 51 malignant) provided no evidence to suggest that mutations in HFE have any outcome modifying activity, although small effects cannot be ruled out. The frequency of HFE mutations was not different in MS compared to the general population.
Descriptors		MULTIPLE SCLEROSIS PROGNOSIS HEMOCHROMATOSIS MUTATION IRON GENOTYPE